|
PL2187965T3
(pl)
|
2007-08-17 |
2020-05-18 |
Purdue Research Foundation |
Koniugaty wiążący psma ligand-łącznik i sposoby ich zastosowania
|
|
WO2009070302A1
(en)
*
|
2007-11-30 |
2009-06-04 |
The Johns Hopkins University |
Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer
|
|
US8855387B2
(en)
|
2007-12-28 |
2014-10-07 |
Exini Diagnostics Ab |
System for detecting bone cancer metastases
|
|
CN107382846B
(zh)
*
|
2008-08-01 |
2021-07-06 |
约翰.霍普金斯大学 |
Psma-结合剂及其用途
|
|
US20120183847A1
(en)
|
2009-05-19 |
2012-07-19 |
Aic Blab |
Composite current collector and methods therefor
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
WO2013028664A1
(en)
*
|
2011-08-22 |
2013-02-28 |
Siemens Medical Solutions Usa, Inc. |
Psma imaging agents
|
|
US20130116404A1
(en)
|
2011-11-08 |
2013-05-09 |
Case Western Reserve University |
Targeted non-invasive imaging probes of egfr expressing cells
|
|
CN113149921B
(zh)
*
|
2011-11-30 |
2024-11-29 |
约翰霍普金斯大学 |
前列腺特异性膜抗原(psma)的同源多价抑制剂和异源多价抑制剂以及其用途
|
|
US20140065070A1
(en)
*
|
2012-08-28 |
2014-03-06 |
Mcmaster University |
Methods of preparing triazole-containing radioiodinated compounds
|
|
MY171561A
(en)
*
|
2012-11-15 |
2019-10-18 |
Endocyte Inc |
Conjugates for treating diseases caused by psma expressing cells
|
|
CN108558939B
(zh)
*
|
2013-03-15 |
2021-08-24 |
癌靶技术有限责任公司 |
18f-标记的靶向psma的pet成像剂
|
|
US10232058B2
(en)
|
2013-10-14 |
2019-03-19 |
The Johns Hopkins University |
Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy
|
|
GEP20237479B
(en)
|
2013-10-18 |
2023-03-27 |
Deutsches Krebsforsch |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
JP6292568B2
(ja)
*
|
2013-11-06 |
2018-03-14 |
国立大学法人京都大学 |
ウレア誘導体化合物、これを含有する放射性医薬
|
|
EP3069147A4
(en)
|
2013-11-14 |
2017-10-11 |
Endocyte, Inc. |
Compounds for positron emission tomography
|
|
US9713649B2
(en)
|
2014-01-24 |
2017-07-25 |
The Cleveland Clinic Foundation |
PSMA-targeting imaging agents
|
|
US10556916B2
(en)
|
2014-04-01 |
2020-02-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography
|
|
EP2993171A1
(en)
*
|
2014-09-04 |
2016-03-09 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for the production of 18F-labeled PSMA-specific PET-tracers
|
|
WO2016030329A1
(en)
*
|
2014-08-24 |
2016-03-03 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for the production of 18f-labeled active esters and their application exemplified by the preparation of a psma-specific pet-tracer
|
|
WO2016062370A1
(en)
*
|
2014-10-20 |
2016-04-28 |
Deutsches Krebsforschungszentrum |
18f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
EP3011976A1
(en)
*
|
2014-10-20 |
2016-04-27 |
Deutsches Krebsforschungszentrum |
18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents
|
|
WO2016065142A2
(en)
*
|
2014-10-22 |
2016-04-28 |
The Johns Hopkins University |
New scaffolds and multifunctional intermediates for imaging psma and cancer therapy
|
|
US10188759B2
(en)
|
2015-01-07 |
2019-01-29 |
Endocyte, Inc. |
Conjugates for imaging
|
|
US20180338910A1
(en)
*
|
2015-01-09 |
2018-11-29 |
The Johns Hopkins University |
Intranasal administration of glutamate carboxypeptidase (gcp-ii) inhibitors
|
|
US10869940B2
(en)
|
2015-06-12 |
2020-12-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Targeted photoacoustic compounds, formulations, and uses thereof
|
|
WO2017029399A1
(en)
*
|
2015-08-20 |
2017-02-23 |
Universität Zu Köln |
Pain tracking by pet-imaging (pain-trap)
|
|
GEP20207106B
(en)
|
2015-09-30 |
2020-05-11 |
Deutsches Krebsforsch |
18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer
|
|
WO2017070482A2
(en)
*
|
2015-10-22 |
2017-04-27 |
The Johns Hopkins University |
Psma targeted radiohalogenated ureas for cancer radiotherapy
|
|
KR101639599B1
(ko)
|
2015-11-09 |
2016-07-14 |
서울대학교산학협력단 |
펩타이드 싸이오우레아 유도체, 이를 포함하는 방사성 동위원소 표지 화합물 및 이를 유효 성분으로 함유하는 전립선암 치료 또는 진단용 약학적 조성물
|
|
EP3400229B1
(en)
|
2016-01-10 |
2024-03-06 |
Provincial Health Services Authority |
18/19f-labelled compounds which target the prostate specific membrane antigen
|
|
EP4497477A3
(en)
*
|
2016-06-10 |
2025-04-02 |
The Johns Hopkins University |
Improved synthesis of the radiolabeled prostate-specific membrane antigen (psma) inhibitor [18f]dcfpyl
|
|
US10806806B2
(en)
|
2016-06-23 |
2020-10-20 |
Cornell University |
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
|
|
EP3474903B1
(en)
*
|
2016-06-23 |
2025-01-22 |
Cornell University |
Double targeted constructs to affect tumor kill
|
|
AU2017348111B2
(en)
|
2016-10-27 |
2023-04-06 |
Progenics Pharmaceuticals, Inc. |
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
|
|
WO2018090976A1
(zh)
*
|
2016-11-17 |
2018-05-24 |
思路迪（北京）医药科技有限公司 |
一种具有抗癌作用的化合物及其制备方法和应用
|
|
DE102016122273B4
(de)
*
|
2016-11-18 |
2018-06-21 |
Abx Advanced Biochemical Compounds Gmbh |
Präkursoren für die Radiofluorierung
|
|
CN117563022A
(zh)
|
2017-04-05 |
2024-02-20 |
康奈尔大学 |
可用于成像和抗肿瘤治疗的具有可调的药代动力学的三功能构建体
|
|
US20230190796A1
(en)
*
|
2017-04-07 |
2023-06-22 |
Juno Therapeutics, Inc. |
Engineered cells expressing prostate-specific membrane antigen (psma) or a modified form thereof and related methods
|
|
JP7373998B2
(ja)
|
2017-05-02 |
2023-11-06 |
コーネル・ユニバーシティー |
有効性がより大きくかつ毒性がより少ない腫瘍標的指向方法及び試薬
|
|
WO2018236115A1
(ko)
|
2017-06-19 |
2018-12-27 |
(주)퓨쳐켐 |
전립선암 진단을 위한 18f-표지된 화합물 및 그의 용도
|
|
MX388833B
(es)
*
|
2017-06-19 |
2025-03-12 |
Futurechem Co Ltd |
Compuesto marcado con 18f para diagnostico de cancer de prostata y uso de este
|
|
WO2019083990A2
(en)
*
|
2017-10-23 |
2019-05-02 |
The Johns Hopkins University |
IMAGING AND RADIATION THERAPY AGENTS TARGETING α-FIBROBLAST ACTIVATION PROTEIN α (FAP-α)
|
|
IL319022A
(en)
*
|
2017-12-11 |
2025-04-01 |
Univ Muenchen Tech |
PSMA imaging and endoradiotherapy ligands
|
|
US10973486B2
(en)
|
2018-01-08 |
2021-04-13 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
|
|
CA3085441A1
(en)
|
2018-01-08 |
2019-07-11 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
|
|
IL276528B2
(en)
|
2018-02-06 |
2024-11-01 |
Univ Johns Hopkins |
PSMA Targeted Radiohalogenated Urea-Polyaminocarboxylates For Cancer Radiotherapy
|
|
WO2019183633A1
(en)
|
2018-03-23 |
2019-09-26 |
Case Western Reserve Univeristy |
Psma targeted conjugate compounds and uses thereof
|
|
SG11202010217YA
(en)
|
2018-04-17 |
2020-11-27 |
Endocyte Inc |
Methods of treating cancer
|
|
CN109160899B
(zh)
*
|
2018-05-16 |
2021-06-04 |
上海如絮生物科技有限公司 |
一种亲水性吡啶类化合物、中间体、其制备方法及应用
|
|
CN109160898B
(zh)
*
|
2018-05-16 |
2021-06-04 |
上海如絮生物科技有限公司 |
一种亲水性吡啶类化合物中间体及其制备方法
|
|
CN109160896B
(zh)
*
|
2018-05-16 |
2021-06-25 |
上海如絮生物科技有限公司 |
一种亲水性吡啶类化合物中间体及其制备方法
|
|
WO2020028323A1
(en)
*
|
2018-07-30 |
2020-02-06 |
The Johns Hopkins Universtiy |
Competitive prostate-specific membrane antigen (psma) binding agents for the reduction of non-target organ uptake of radiolabeled psma inhibitors for psma positive tumor imaging and radiopharmaceutical therapy
|
|
CN113164450A
(zh)
|
2018-10-11 |
2021-07-23 |
普罗热尼奇制药公司 |
用于治疗转移性前列腺癌的组合治疗
|
|
RU2697519C1
(ru)
*
|
2018-10-15 |
2019-08-15 |
Общество с ограниченной ответственностью "Изварино Фарма" |
Средство пептидной природы, включающее псма-связывающий лиганд на основе производного мочевины, способ его получения и применение для получения конъюгата с лекарственным и диагностическим агентом
|
|
KR102403970B1
(ko)
|
2018-12-27 |
2022-05-31 |
(주)퓨쳐켐 |
카르복시산이 도입된 psma-표적 화합물 및 그의 용도
|
|
JP7568628B2
(ja)
|
2019-01-07 |
2024-10-16 |
エクシーニ ディアグノスティクス アーべー |
プラットホーム非依存の全身画像セグメント化のためのシステムおよび方法
|
|
PL239934B1
(pl)
|
2019-04-12 |
2022-01-31 |
Narodowe Centrum Badan Jadrowych Osrodek Radioizotopow Polatom |
Pochodne inhibitorów PSMA do znakowania ⁹⁹ᵐTc poprzez HYNIC, zestaw radiofarmaceutyczny, preparat radiofarmaceutyczny oraz ich zastosowanie w diagnostyce raka prostaty
|
|
CA3136979A1
(en)
|
2019-04-17 |
2020-10-22 |
Provincial Health Services Authority |
Radiolabelled compounds for diagnosis or treatment of prostate-spe cific membrane antigen-expressing cancer
|
|
EP4564288A3
(en)
|
2019-04-24 |
2025-09-17 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for automated and interactive analysis of bone scan images for detection of metastases
|
|
EP3959683A1
(en)
|
2019-04-24 |
2022-03-02 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for interactive adjustment of intensity windowing in nuclear medicine images
|
|
US12473265B2
(en)
|
2019-05-20 |
2025-11-18 |
Endocyte, Inc. |
Methods for preparing PSMA conjugates
|
|
CN119431260A
(zh)
|
2019-06-21 |
2025-02-14 |
省卫生服务机构 |
靶向前列腺特异性膜抗原的放射性标记化合物
|
|
RU2713151C1
(ru)
*
|
2019-07-02 |
2020-02-04 |
Общество с ограниченной ответственностью "Изварино Фарма" |
Конъюгат флуоресцентного красителя с веществом пептидной природы, включающим псма-связывающий лиганд на основе производного мочевины для визуализации клеток, экспрессирующих псма, способ его получения и применения
|
|
WO2021041896A1
(en)
*
|
2019-08-30 |
2021-03-04 |
Memorial Sloan Kettering Cancer Center |
Novel theranostic agents for psma positive cancers
|
|
US11544407B1
(en)
|
2019-09-27 |
2023-01-03 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for secure cloud-based medical image upload and processing
|
|
US11564621B2
(en)
|
2019-09-27 |
2023-01-31 |
Progenies Pharmacenticals, Inc. |
Systems and methods for artificial intelligence-based image analysis for cancer assessment
|
|
US12417533B2
(en)
|
2019-09-27 |
2025-09-16 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for artificial intelligence-based image analysis for cancer assessment
|
|
US11900597B2
(en)
|
2019-09-27 |
2024-02-13 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for artificial intelligence-based image analysis for cancer assessment
|
|
KR102269315B1
(ko)
|
2019-10-24 |
2021-06-24 |
서울대학교산학협력단 |
전립선 암의 영상 또는 치료를 위한 동위원소 표지 화합물
|
|
US11386988B2
(en)
|
2020-04-23 |
2022-07-12 |
Exini Diagnostics Ab |
Systems and methods for deep-learning-based segmentation of composite images
|
|
US11321844B2
(en)
|
2020-04-23 |
2022-05-03 |
Exini Diagnostics Ab |
Systems and methods for deep-learning-based segmentation of composite images
|
|
CN111548305B
(zh)
*
|
2020-05-12 |
2021-08-31 |
北京师范大学 |
一种可用于靶向psma的喹啉类化合物及其制备方法
|
|
US11721428B2
(en)
|
2020-07-06 |
2023-08-08 |
Exini Diagnostics Ab |
Systems and methods for artificial intelligence-based image analysis for detection and characterization of lesions
|
|
CN116134479A
(zh)
|
2020-07-06 |
2023-05-16 |
西尼诊断公司 |
用于检测及表征化病变的基于人工智能的图像分析系统及方法
|
|
WO2022101352A1
(en)
|
2020-11-12 |
2022-05-19 |
Abx Advanced Biochemical Compounds Gmbh |
Ligands of prostate specific membrane antigen (psma) containing heteroaromatic linker building blocks
|
|
CN114685599A
(zh)
*
|
2020-12-30 |
2022-07-01 |
南京江原安迪科正电子研究发展有限公司 |
一种psma靶向抑制剂及放射性核素标记的psma靶向抑制剂、制备方法和用途
|
|
US20240293586A1
(en)
|
2021-07-30 |
2024-09-05 |
Osaka University |
Radiolabeled compound and use thereof
|
|
CA3231578A1
(en)
|
2021-10-08 |
2023-04-13 |
Exini Diagnostics Ab |
Systems and methods for automated identification and classification of lesions in local lymph and distant metastases
|
|
AU2022388735A1
(en)
|
2021-11-09 |
2024-05-30 |
Case Western Reserve University |
Psma targeted conjugate compounds and uses thereof
|
|
US20230410985A1
(en)
|
2022-06-08 |
2023-12-21 |
Exini Diagnostics Ab |
Systems and methods for assessing disease burden and progression
|
|
KR20250130683A
(ko)
|
2023-01-10 |
2025-09-02 |
썬 파마 어드밴스트 리서치 컴패니 리미티드 |
리간드-약물 접합체
|
|
US20240285248A1
(en)
|
2023-02-13 |
2024-08-29 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for predicting biochemical progression free survival in prostate cancer patients
|
|
CN116217505B
(zh)
*
|
2023-03-17 |
2024-10-01 |
南京医科大学 |
用于诊断或治疗表达前列腺特异性膜抗原癌症的新型标记靶向剂
|
|
WO2024211651A1
(en)
|
2023-04-07 |
2024-10-10 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for facilitating lesion inspection and analysis
|
|
WO2025072177A1
(en)
|
2023-09-25 |
2025-04-03 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for automated cancer staging and risk prediction
|
|
WO2025090594A1
(en)
*
|
2023-10-25 |
2025-05-01 |
The Johns Hopkins University |
Deep transfer learning for fully automated tumor quantification and prognosis of cancer on pet/ct
|
|
DE102023133281B8
(de)
*
|
2023-11-28 |
2025-07-24 |
Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien Gmbh |
Radiotracer und Präkursoren für diese Radiotracer sowie Verwendung dieser Radiotracer als Diagnostika und Therapeutika
|
|
CN117670883B
(zh)
*
|
2024-01-31 |
2024-05-07 |
中国医学科学院北京协和医院 |
一种鉴别高低级别膀胱癌的方法、设备和系统
|